Treatment of Thrombotic Thrombocytopenic Purpura in Pregnancy
A pair of researchers discuss the treatment and specific clinical challenges associated with thrombotic thrombocytopenic purpura in women who are pregnant.
Diagnosis & Disease Information
Elevated Plasma Syndecan-1, Thrombomodulin Linked to Exacerbated Immune-Mediated Thrombotic Thrombocytopenic Purpura
Hospitalized patients with elevated Sdc-1 levels have a higher risk for death in patients with iTTP. Levels may be used for risk stratification.
Screening for Gaucher Disease in Canadian Patients With Thrombocytopenia
A single-center study in Canada found a point prevalence of Gaucher disease of 0.5% among Canadian patients referred to a hematologist for thrombocytopenia.
Acute Thrombotic Thrombocytopenic Purpura: Abnormal MRI Linked to Cognitive Impairment
Cerebral MRI data suggest that neurological symptoms and cognitive impairment may be common among patients with an acute TTP event.
Outcomes of Systemic Lupus Erythematosus in Immune-Mediated Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura (TTP) related to systemic lupus erythematosus may not cause worse outcomes compared with primary immune-mediated TTP.
Level of Health Literacy Among Patients With Thrombotic Thrombocytopenic Purpura
A team of investigators evaluated knowledge gaps among patients with TTP in remission and found a range of levels of understanding of the condition.
Thrombotic Thrombocytopenic Purpura: Expert Recommendations, Good Practice Statements for Critical Care
TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.
Cytomegalovirus-Associated Thrombocytopenia in Immunocompetent Adults
Investigators conducted a large case series of CMV-linked thrombocytopenia to highlight treatment and response in immunocompetent adults.
Caplacizumab Safe, Effective for Acquired Thrombotic Thrombocytopenic Purpura
Caplacizumab appears to be safe and effective among patients with acquired thrombotic thrombocytopenic purpura treated in the real-world setting.
Model for Predicting Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura
Investigators developed an accurate prediction model for the early identification of refractory immune-mediated TTP.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...